Clinical trial · Observational
A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors
NCT00706875CI-TRIAL-00032709completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to collect information on the effects of treatment for gestational trophoblastic disease (GTD). We plan to use the findings from this study to better understand GTD survivors' health and quality of life. We would like to know more about the health, quality of life and pregnancies of women treated for GTD. This information will be used to try and improve the treatments for women who have this disease.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervix Uteri Nos | — | UNRESOLVED | — |
| Gestational Trophoblastic Disease | Gestational Trophoblastic Tumor | ALIAS | 0.90 |
| Uterine Cancer | Malignant Uterine Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| questionnaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- 1
- description
- 30 patients survived GTD post treatment for 0 - 5 years.
- interventionNames
- Behavioral: questionnaire
- label
- 2
- description
- 30 patients survived GTD post treatment 6 - 10+ years.
- interventionNames
- Behavioral: questionnaire
Primary outcomes (1)
- measure
- The primary outcomes include reproductive concerns (as measured by the Reproductive Concern Scale, RCS) and sexual functioning (as measured by the Female Sexual Function Index, FSFI).
- timeFrame
- conclusion of the study
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Pathology confirmed GTD by MSKCC * Sufficient proficiency in the English language to respond to quality of life surveys * Age ≥ 18 years * Benign or malignant disease * Treated with surgery and/or chemotherapy or observation Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.